Literature DB >> 19584288

Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.

Pei-Ching Chang1, Latricia D Fitzgerald, Albert Van Geelen, Yoshihiro Izumiya, Thomas J Ellison, Don-Hong Wang, David K Ann, Paul A Luciw, Hsing-Jien Kung.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) has been linked to the development of Kaposi's sarcoma, a major AIDS-associated malignancy, and to hematologic malignancies, including primary effusion lymphoma and multicentric Castleman's disease. Like other herpesviruses, KSHV is capable of both latent and lytic replication. Understanding the molecular details associated with this transition from latency to lytic replication is key to controlling virus spread and can affect the development of intervention strategies. Here, we report that Kruppel-associated box domain-associated protein-1 (KAP-1)/transcriptional intermediary factor 1beta, a cellular transcriptional repressor that controls chromosomal remodeling, participates in the process of switching viral latency to lytic replication. Knockdown of KAP-1 by small interfering RNA leads to KSHV reactivation mediated by K-Rta, a key transcriptional regulator. In cells harboring latent KSHV, KAP-1 was associated with the majority of viral lytic-gene promoters. K-Rta overexpression induced the viral lytic cycle with concomitant reduction of KAP-1 binding to viral promoters. Association of KAP-1 with heterochromatin was modulated by both sumoylation and phosphorylation. During lytic replication of KSHV, KAP-1 was phosphorylated at Ser(824). Several lines of evidence directly linked the viral protein kinase to this post-translational modification. Additional studies showed that this phosphorylation of KAP-1 produced a decrease in its sumoylation, consequently decreasing the ability of KAP-1 to condense chromatin on viral promoters. In summary, the cellular transcriptional repressor KAP-1 plays a role in regulating KSHV latency, and viral protein kinase modulates the chromatin remodeling function of this repressor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584288      PMCID: PMC2731626          DOI: 10.1158/0008-5472.CAN-08-4570

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.

Authors:  David C Schultz; Kasirajan Ayyanathan; Dmitri Negorev; Gerd G Maul; Frank J Rauscher
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.

Authors:  Shuhei Sakakibara; Keiji Ueda; Ken Nishimura; Eunju Do; Eriko Ohsaki; Toshiomi Okuno; Koichi Yamanishi
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

4.  A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.

Authors:  C Underhill; M S Qutob; S P Yee; J Torchia
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

5.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Jeffrey Vieira; Patricia M O'Hearn
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

6.  Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.

Authors:  Harinivas H Krishnan; Pramod P Naranatt; Marilyn S Smith; Ling Zeng; Clark Bloomer; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 7.  Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.

Authors:  Abel Viejo-Borbolla; Thomas F Schulz
Journal:  AIDS Rev       Date:  2003 Oct-Dec       Impact factor: 2.500

8.  Sti1 and Cdc37 can stabilize Hsp90 in chaperone complexes with a protein kinase.

Authors:  Paul Lee; Arsalan Shabbir; Christopher Cardozo; Avrom J Caplan
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

9.  Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.

Authors:  Hiroyuki Nakamura; Michael Lu; Yousang Gwack; John Souvlis; Steven L Zeichner; Jae U Jung
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Control of cytomegalovirus lytic gene expression by histone acetylation.

Authors:  Jane C Murphy; Wolfgang Fischle; Eric Verdin; John H Sinclair
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

View more
  63 in total

1.  Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.

Authors:  Mel Campbell; Pei-Ching Chang; Steve Huerta; Chie Izumiya; Ryan Davis; Clifford G Tepper; Kevin Y Kim; Bogdan Shevchenko; Don-Hong Wang; Jae U Jung; Paul A Luciw; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

2.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

3.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

4.  Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor.

Authors:  Pei-Ching Chang; Latricia D Fitzgerald; Datsun A Hsia; Yoshihiro Izumiya; Chun-Yi Wu; Wen-Ping Hsieh; Su-Fang Lin; Mel Campbell; Kit S Lam; Paul A Luciw; Clifford G Tepper; Hsing-Jien Kung
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.

Authors:  Olsi Gjyshi; Arunava Roy; Sujoy Dutta; Mohanan Valiya Veettil; Dipanjan Dutta; Bala Chandran
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

6.  A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages.

Authors:  Bryan C Mounce; Wadzanai P Mboko; Tarin M Bigley; Scott S Terhune; Vera L Tarakanova
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

7.  Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.

Authors:  Xiaofan Li; Sergei V Kozlov; Ayman El-Guindy; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

8.  Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection.

Authors:  Natalie A Forrester; Rakesh N Patel; Thomas Speiseder; Peter Groitl; Garry G Sedgwick; Neil J Shimwell; Robert I Seed; Pól Ó Catnaigh; Christopher J McCabe; Grant S Stewart; Thomas Dobner; Roger J A Grand; Ashley Martin; Andrew S Turnell
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

9.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

10.  STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Christine A King; Xiaofan Li; Arturo Barbachano-Guerrero; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.